Journal article
Recent advances and impending challenges for the radiopharmaceutical sciences in oncology
The lancet oncology, Vol.25(6), pp.e236-e249
06/2024
DOI: 10.1016/S1470-2045(24)00030-5
PMCID: PMC11340123
PMID: 38821098
Abstract
This paper is the first of a Series on theranostics that summarises the current landscape of the radiopharmaceutical sciences as they pertain to oncology. In this Series paper, we describe exciting developments in radiochemistry and the production of radionuclides, the development and translation of theranostics, and the application of artificial intelligence to our field. These developments are catalysing growth in the use of radiopharmaceuticals to the benefit of patients worldwide. We also highlight some of the key issues to be addressed in the coming years to realise the full potential of radiopharmaceuticals to treat cancer.
Details
- Title: Subtitle
- Recent advances and impending challenges for the radiopharmaceutical sciences in oncology
- Creators
- Suzanne E Lapi - University of Alabama at BirminghamPeter J H Scott - University of MichiganAndrew M Scott - The University of MelbourneAlbert D Windhorst - Vrije Universiteit AmsterdamBrian M Zeglis - Hunter CollegeMay Abdel-Wahab - International Atomic Energy AgencyRichard P Baum - Deutsche Klinik für DiagnostikJohn M Buatti - University of IowaFrancesco Giammarile - International Atomic Energy AgencyAna P Kiess - Johns Hopkins UniversityAmirreza Jalilian - International Atomic Energy AgencyPeter Knoll - International Atomic Energy AgencyAruna Korde - International Atomic Energy AgencyJolanta Kunikowska - Medical University of WarsawSze Ting Lee - The University of MelbourneDiana Paez - International Atomic Energy AgencyJean-Luc Urbain - Roswell Park Comprehensive Cancer CenterJingjing Zhang - National University of SingaporeJason S Lewis - Cornell University
- Resource Type
- Journal article
- Publication Details
- The lancet oncology, Vol.25(6), pp.e236-e249
- DOI
- 10.1016/S1470-2045(24)00030-5
- PMID
- 38821098
- PMCID
- PMC11340123
- NLM abbreviation
- Lancet Oncol
- ISSN
- 1470-2045
- eISSN
- 1474-5488
- Publisher
- Elsevier Ltd
- Language
- English
- Date published
- 06/2024
- Academic Unit
- Radiation Oncology; Neurosurgery; Otolaryngology
- Record Identifier
- 9984635159302771
Metrics
12 Record Views